ABCL

#2371
AbCellera Biologics Inc. Common Shares
3.76 USD
+2.73%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
3.76
3.76
Rango anual
1.94
6.52
Cambio diario
+2.73%
Variación mensual
+6.52%
Variación en los últimos 6 meses
-33.69%
Cambio anual
+55.37%
Cierres anteriores
3.66
Abrir
3.76
Bid
Ask
Mínimo
3.76
High
3.76
Volumen
45
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 1.14 B
  • Employee 562
  • Founded 2012
  • CEO Carl Hansen
  • Website www.abcellera.com
  • Headquarter British Columbia, Canada
  • FIGI BBG00LLW2MF2
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-6.98
Relación precio/flujo de caja
13.6

AbCellera Biologics Inc

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

Noticias